Theravance Biopharma's total assets for Q1 2025 were $343.58M, a decrease of -2.99% from the previous quarter. TBPH total liabilities were $177.60M for the fiscal quarter, a -0.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.